MS

Methari Sandhya Rani

Active Director Managing Director DIN 10928636
DIN 10928636 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Methari Sandhya Rani

Data last updated:

Methari Sandhya Rani is a Managing Director at Novas Msb Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10928636
Primary Designation Managing Director
Industry Pharma
First Appointment 18 Feb 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director18 Feb 20252025Active

Board colleagues of Methari Sandhya Rani

NameDINCompanyDesignation
Methari Soujanya09084306Novas Msb Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novas Msb Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Methari Sandhya Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Methari Sandhya Rani

Methari Sandhya Rani currently holds 1 directorship: Novas Msb Pharmaceuticals Private Limited (Managing Director, since 18 Feb 2025).

Methari Sandhya Rani was first appointed on 18 Feb 2025 as Managing Director at Novas Msb Pharmaceuticals Private Limited.

The current boards of Methari Sandhya Rani's companies include Methari Soujanya (Novas Msb Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available